Fidelity Investments’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.04K | Sell |
|
|||||
|
2025
Q1 | $15.5K | Buy |
|
|||||
|
2024
Q4 | $10.8K | Buy |
|
|||||
|
2024
Q3 | $15.8K | Sell |
|
|||||
|
2024
Q2 | $36.5K | Sell |
|
|||||
|
2024
Q1 | $54.7K | Sell |
|
|||||
|
2023
Q4 | $1.13M | Sell |
|
|||||
|
2023
Q3 | $15.9M | Sell |
|
|||||
|
2023
Q2 | $26.7M | Buy |
|
|||||
|
2023
Q1 | $25.9M | Sell |
|
|||||
|
2022
Q4 | $27.7M | Sell |
|
|||||
|
2022
Q3 | $30.7M | Buy |
|
|||||
|
2022
Q2 | $22.5M | Sell |
|
|||||
|
2022
Q1 | $37.1M | Sell |
|
|||||
|
2021
Q4 | $73.9M | Sell |
|
|||||
|
2021
Q3 | $220M | Buy |
|
|||||
|
2021
Q2 | $188M | Buy |
|
|||||
|
2021
Q1 | $271M | Buy |
|
|||||
|
2020
Q4 | $296M | Buy |
|
|||||
|
2020
Q3 | $90.1M | Buy |
|